Due to high demand our next available consultation time is Thursday 8th October.
Average body weight over time at each medication's highest trial dose, alongside a reduced-calorie diet and more physical activity.
/* Figures come from separate clinical trials that cannot be directly compared, and individual results vary. 1 SURMOUNT-1 (tirzepatide 15mg, 72 weeks), 2 STEP 1 (semaglutide 2.4mg, 68 weeks), 3 OASIS 4 (oral semaglutide 25mg, 64 weeks), 4 ATTAIN (orforglipron 17.2mg, 72 weeks), 5 XENDOS (orlistat, 4 years). Your doctor confirms what is clinically appropriate for you. */
You speak to a doctor, not a pharmacist, and not just a form. Treatment can be with you in {{ deliveryDays }} days.
A few minutes online, covering your history and current health.
Your GMC-registered doctor confirms the medication and dose that suit you.
Dispensed and delivered by our partner pharmacy, tracked to your door.
1:1 coaching, weekly live sessions and daily support in the app.
The UK's complete weight-management programme.
Doctor-led care with our own coaching and app.
© Saxonvale UK Limited. All rights reserved. Everwell is a trading name of Saxonvale UK Limited. Registered office at 61 Bridge Street, Kington, United Kingdom, HR5 3DJ. Registered in England and Wales, company number 17097136. Healthcare services are provided by AccessGP Limited (CQC Registration Number: 1-22271946259).
Medicines are dispensed & delivered by PHARMKG LTD trading as Pharmacy + Me (GPhC Registration Number: 9013270) with Superintendent Pharmacist Konstantin Gkioka (GPhC Registration Number: 2224520).